While advances in CF therapy, especially in CFTR modulation, have resulted in an older and healthier CF population, many needs of women with cystic fibrosis remain unmet. Evidence-based guidance is incomplete: about pregnancy, contraception, the effect of sex differences in trial outcomes, what role (if any) female sex hormones might play, et al.
In this issue of eCysticFibrosis Review, Dr. Natalie West from Johns Hopkins University in Baltimore and Dr. Traci Kazmerski from UPMC Children's Hospital of Pittsburgh analyze the current data describing the disease-specific sexual and reproductive health concerns of women with cystic fibrosis.
Assistant Professor of Medicine
Associate Program Director, Pulmonary and Critical Care Fellowship
Pulmonary and Critical Care Medicine
Johns Hopkins University
Baltimore, MD
Assistant Professor of Pediatrics
Division of Adolescent and Young Adult Medicine
UPMC Children's Hospital of Pittsburgh
Pittsburgh, PA
Director, Adult Cystic Fibrosis Program
Associate Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, MD
Professor of Pediatrics
Director, Cystic Fibrosis Center
Johns Hopkins University School of Medicine
Baltimore, MD
Clinical Nurse
Pediatric Clinic Coordinator
Johns Hopkins Cystic Fibrosis Center
Baltimore, MD
1.0 hour Physicians
1.0 contact hour Nurses
Launch date: October 28, 2020
Expiration date: October 27, 2022